HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Miyoshi distal myopathy: specific signs and incidence].

Abstract
We report 21 French patients (12 males and 9 females), presenting a distal myopathy of Miyoshi type. The main clinical features of these patients were 1) onset in late adolescence or early adulthood (mean age: 20.3 years), 2) early and predominant involvement of the posterior compartment muscles of legs, 3) marked elevation of serum CK (from 10 to 50 times the normal value), 4) dystrophic features with a necrotic regeneration pattern without vacuole in muscle biopsy. All cases were sporadic and a consanguinity of parents was found in five cases. The clinical course was relatively mild: twelve patients could walk without aid; However four patients were severely disabled. Four patients were initially considered as having polymyositis; corticosteroids and immunosuppressive drugs were always inefficient. A genetic linkage to chromosome 2 was ascertained in five cases. In our experience the Miyoshi distal myopathy is the most common form of distal myopathy, particularly in young patients.
AuthorsB Eymard, P Laforêt, F M Tomé, H Collin, J P Leroy, J J Hauw, I Richard, J Beckmann, M Fardeau
JournalRevue neurologique (Rev Neurol (Paris)) Vol. 156 Issue 2 Pg. 161-8 (Feb 2000) ISSN: 0035-3787 [Print] France
Vernacular TitleMyopathie distale de type Miyoshi: séméiologie particulière et fréquence.
PMID10743015 (Publication Type: English Abstract, Journal Article)
Topics
  • Adolescent
  • Adult
  • Age of Onset
  • Female
  • France (epidemiology)
  • Humans
  • Incidence
  • Leg
  • Male
  • Muscle, Skeletal (pathology, physiopathology)
  • Muscular Dystrophies (diagnosis, epidemiology, physiopathology)
  • Walking

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: